Amphastar Pharmaceuticals, Inc. (AMPH)
25.78
-0.29
(-1.11%)
USD |
NASDAQ |
Jan 20, 10:26
Amphastar Pharmaceuticals Total Liabilities (Quarterly): 889.48M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Pfizer Inc. | 115.64B |
| Supernus Pharmaceuticals, Inc. | 370.09M |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| CorMedix, Inc. | 376.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.666B |
| Shareholders Equity (Quarterly) | 776.75M |
| Debt to Equity Ratio | 0.8455 |
| Current Ratio | 3.116 |
| Net Debt Paydown Yield | -0.59% |